Trials Sponsors Conditions Drugs Pricing

Conditions

Obsessive-Compulsive Disorder

Outcome Measures

Primary Outcomes (1)

quality of life scale
assess the quality of life in OCD patients
about 6 months

Study Arms (2)

Group 1 (Patients)

Patients: 37 patients with OCD diagnosed according to DSM-5 1. Inclusion criteria: 1. both sex 2. age groups : 18 : 60 are included 3. accept to participate in the study 2. Exclusion criteria 1. presence of major neurological disease as head trauma and sensory or motor defect as blindness or deafness 2. Active psychiatric disordes 3. patients refuse to participate in the study

Group 2 (Controlled)

37 healthy populations matched with PT group in age , sex , socioeconomic state

Behavioral: Quality of life scale

Interventions

Quality of life scaleBehavioral

1. To assess the quality of life of patient 2. To assess the degree of OCD

Also known as: Yale-Brown Obsessive-Compulsive Scale

Group 2 (Controlled)

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

1. Psychiatric interview 2. Diagnosis : according to DSM-.5 using Yale-Brown Obsessive-Compulsive Scale for diagnosis and severity 3. Psychiatric comorbidity : SCID I -SCID II scale 4. Socioeconomic state 5. Quality of life scale 6. EEG

You may qualify if:

\. both sex 2. age groups : 18 : 60 are included 3. accept to participate in the study

Sponsors & Collaborators

Assiut University
Otherlead

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Assistant Professor of Psychiatry

Study Record Dates

First Submitted

October 26, 2021

First Posted

November 3, 2021

Study Start

November 1, 2021

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

December 1, 2021

Psychiatric Comorbidity and Quality of Life in Patients With Obsessive Compulsive Disorder(Case Control Study )

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Group 1 (Patients)

Group 2 (Controlled)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Group 1 (Patients)

Group 2 (Controlled)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record